001     138990
005     20240524120326.0
024 7 _ |a 10.1194/jlr.M068676
|2 doi
024 7 _ |a pmid:27881717
|2 pmid
024 7 _ |a pmc:PMC5234710
|2 pmc
024 7 _ |a 0022-2275
|2 ISSN
024 7 _ |a 1539-7262
|2 ISSN
024 7 _ |a altmetric:15391718
|2 altmetric
037 _ _ |a DZNE-2020-05312
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Alecu, Irina
|b 0
245 _ _ |a Localization of 1-deoxysphingolipids to mitochondria induces mitochondrial dysfunction.
260 _ _ |a Bethesda, Md.
|c 2017
|b ASBMB
264 _ 1 |3 online
|2 Crossref
|b American Society for Biochemistry & Molecular Biology (ASBMB)
|c 2016-11-23
264 _ 1 |3 print
|2 Crossref
|b American Society for Biochemistry & Molecular Biology (ASBMB)
|c 2017-01-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1716472934_3149
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a 1-Deoxysphingolipids (deoxySLs) are atypical sphingolipids that are elevated in the plasma of patients with type 2 diabetes and hereditary sensory and autonomic neuropathy type 1 (HSAN1). Clinically, diabetic neuropathy and HSAN1 are very similar, suggesting the involvement of deoxySLs in the pathology of both diseases. However, very little is known about the biology of these lipids and the underlying pathomechanism. We synthesized an alkyne analog of 1-deoxysphinganine (doxSA), the metabolic precursor of all deoxySLs, to trace the metabolism and localization of deoxySLs. Our results indicate that the metabolism of these lipids is restricted to only some lipid species and that they are not converted to canonical sphingolipids or fatty acids. Furthermore, exogenously added alkyne-doxSA [(2S,3R)-2-aminooctadec-17-yn-3-ol] localized to mitochondria, causing mitochondrial fragmentation and dysfunction. The induced mitochondrial toxicity was also shown for natural doxSA, but not for sphinganine, and was rescued by inhibition of ceramide synthase activity. Our findings therefore indicate that mitochondrial enrichment of an N-acylated doxSA metabolite may contribute to the neurotoxicity seen in diabetic neuropathy and HSAN1. Hence, we provide a potential explanation for the characteristic vulnerability of peripheral nerves to elevated levels of deoxySLs.
536 _ _ |a 341 - Molecular Signaling (POF3-341)
|0 G:(DE-HGF)POF3-341
|c POF3-341
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Lipids
|2 NLM Chemicals
650 _ 7 |a Sphingolipids
|2 NLM Chemicals
650 _ 7 |a Oxidoreductases
|0 EC 1.-
|2 NLM Chemicals
650 _ 7 |a dihydroceramide desaturase
|0 EC 1.3.1.-
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Diabetes Mellitus, Type 2: blood
|2 MeSH
650 _ 2 |a Diabetes Mellitus, Type 2: pathology
|2 MeSH
650 _ 2 |a Diabetic Neuropathies: blood
|2 MeSH
650 _ 2 |a Diabetic Neuropathies: pathology
|2 MeSH
650 _ 2 |a Hereditary Sensory and Autonomic Neuropathies: blood
|2 MeSH
650 _ 2 |a Hereditary Sensory and Autonomic Neuropathies: pathology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Lipids: blood
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Mitochondria: drug effects
|2 MeSH
650 _ 2 |a Mitochondria: metabolism
|2 MeSH
650 _ 2 |a Mitochondria: pathology
|2 MeSH
650 _ 2 |a Oxidoreductases: metabolism
|2 MeSH
650 _ 2 |a Peripheral Nerves: metabolism
|2 MeSH
650 _ 2 |a Peripheral Nerves: pathology
|2 MeSH
650 _ 2 |a Sphingolipids: blood
|2 MeSH
650 _ 2 |a Sphingolipids: chemical synthesis
|2 MeSH
650 _ 2 |a Sphingolipids: pharmacology
|2 MeSH
700 1 _ |a Tedeschi, Andrea
|0 P:(DE-2719)2810470
|b 1
|u dzne
700 1 _ |a Behler, Natascha
|b 2
700 1 _ |a Wunderling, Klaus
|b 3
700 1 _ |a Lamberz, Christian
|0 P:(DE-2719)2811203
|b 4
|u dzne
700 1 _ |a Lauterbach, Mario A R
|b 5
700 1 _ |a Gaebler, Anne
|b 6
700 1 _ |a Ernst, Daniela
|b 7
700 1 _ |a Van Veldhoven, Paul P
|b 8
700 1 _ |a Alamoudi, Ashraf
|0 P:(DE-2719)2259138
|b 9
|u dzne
700 1 _ |a Latz, Eicke
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Othman, Alaa
|b 11
700 1 _ |a Kuerschner, Lars
|b 12
700 1 _ |a Hornemann, Thorsten
|b 13
700 1 _ |a Bradke, Frank
|0 P:(DE-2719)2810270
|b 14
|u dzne
700 1 _ |a Thiele, Christoph
|b 15
700 1 _ |a Penno, Anke
|0 P:(DE-HGF)0
|b 16
|e Corresponding author
773 1 8 |a 10.1194/jlr.m068676
|b : American Society for Biochemistry & Molecular Biology (ASBMB), 2016-11-23
|n 1
|p 42-59
|3 journal-article
|2 Crossref
|t Journal of Lipid Research
|v 58
|y 2016
|x 0022-2275
773 _ _ |a 10.1194/jlr.M068676
|g Vol. 58, no. 1, p. 42 - 59
|0 PERI:(DE-600)1466675-3
|n 1
|q 58:1<42 - 59
|p 42-59
|t Journal of lipid research
|v 58
|y 2017
|x 0022-2275
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/138990/files/DZNE-2020-05312.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/138990/files/DZNE-2020-05312.pdf?subformat=pdfa
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234710
909 C O |o oai:pub.dzne.de:138990
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2810470
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2811203
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2259138
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2810270
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-341
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Molecular Signaling
|x 0
914 1 _ |y 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-18
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J LIPID RES : 2021
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2022-08-11T09:56:38Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2022-08-11T09:56:38Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-18
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2022-08-11T09:56:38Z
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J LIPID RES : 2021
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-18
920 1 _ |0 I:(DE-2719)1013002
|k AG Bradke
|l Axon Growth and Regeneration
|x 0
920 1 _ |0 I:(DE-2719)1013012
|k AG Alamoudi
|l Cryo-electron microscopy and tomography
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013002
980 _ _ |a I:(DE-2719)1013012
980 1 _ |a FullTexts
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M808798200
|2 Crossref
|o 10.1074/jbc.M808798200
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M109.092973
|2 Crossref
|o 10.1074/jbc.M109.092973
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awh712
|2 Crossref
|o 10.1093/brain/awh712
999 C 5 |9 -- missing cx lookup --
|a 10.1038/85817
|2 Crossref
|o 10.1038/85817
999 C 5 |9 -- missing cx lookup --
|a 10.1038/85879
|2 Crossref
|o 10.1038/85879
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.ejmg.2013.02.002
|2 Crossref
|o 10.1016/j.ejmg.2013.02.002
999 C 5 |9 -- missing cx lookup --
|a 10.1002/humu.21481
|2 Crossref
|o 10.1002/humu.21481
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0b013e318295d789
|2 Crossref
|o 10.1212/WNL.0b013e318295d789
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s12017-014-8339-1
|2 Crossref
|o 10.1007/s12017-014-8339-1
999 C 5 |9 -- missing cx lookup --
|a 10.1093/hmg/ddv611
|2 Crossref
|o 10.1093/hmg/ddv611
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0960-8966(12)70050-0
|2 Crossref
|o 10.1016/S0960-8966(12)70050-0
999 C 5 |9 -- missing cx lookup --
|a 10.1523/JNEUROSCI.2536-09.2009
|2 Crossref
|o 10.1523/JNEUROSCI.2536-09.2009
999 C 5 |9 -- missing cx lookup --
|a 10.1172/JCI57549
|2 Crossref
|o 10.1172/JCI57549
999 C 5 |9 -- missing cx lookup --
|a 10.1093/hmg/ddv390
|2 Crossref
|o 10.1093/hmg/ddv390
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00125-011-2384-1
|2 Crossref
|o 10.1007/s00125-011-2384-1
999 C 5 |9 -- missing cx lookup --
|a 10.1186/1476-511X-9-84
|2 Crossref
|o 10.1186/1476-511X-9-84
999 C 5 |9 -- missing cx lookup --
|a 10.1136/bmjdrc-2014-000073
|2 Crossref
|o 10.1136/bmjdrc-2014-000073
999 C 5 |9 -- missing cx lookup --
|a 10.2337/db14-1325
|2 Crossref
|o 10.2337/db14-1325
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.273.30.19060
|2 Crossref
|o 10.1074/jbc.273.30.19060
999 C 5 |9 -- missing cx lookup --
|a 10.1021/jo400440z
|2 Crossref
|o 10.1021/jo400440z
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M114.603860
|2 Crossref
|o 10.1074/jbc.M114.603860
999 C 5 |9 -- missing cx lookup --
|a 10.1194/jlr.P056002
|2 Crossref
|o 10.1194/jlr.P056002
999 C 5 |9 -- missing cx lookup --
|a 10.1096/fj.15-272567
|2 Crossref
|o 10.1096/fj.15-272567
999 C 5 |9 -- missing cx lookup --
|a 10.1194/jlr.M067033
|2 Crossref
|o 10.1194/jlr.M067033
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.molcel.2012.04.033
|2 Crossref
|o 10.1016/j.molcel.2012.04.033
999 C 5 |9 -- missing cx lookup --
|a 10.1083/jcb.113.6.1267
|2 Crossref
|o 10.1083/jcb.113.6.1267
999 C 5 |9 -- missing cx lookup --
|a 10.1194/jlr.D038653
|2 Crossref
|o 10.1194/jlr.D038653
999 C 5 |9 -- missing cx lookup --
|a 10.1021/cb300414v
|2 Crossref
|o 10.1021/cb300414v
999 C 5 |9 -- missing cx lookup --
|a 10.1194/jlr.D044727
|2 Crossref
|o 10.1194/jlr.D044727
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.cellsig.2009.11.001
|2 Crossref
|o 10.1016/j.cellsig.2009.11.001
999 C 5 |9 -- missing cx lookup --
|a 10.1002/1522-7189(199911/12)7:6<407::AID-NT84>3.0.CO;2-0
|2 Crossref
|o 10.1002/1522-7189(199911/12)7:6<407::AID-NT84>3.0.CO;2-0
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nmeth.2019
|2 Crossref
|o 10.1038/nmeth.2019
999 C 5 |9 -- missing cx lookup --
|a 10.1038/ni907
|2 Crossref
|o 10.1038/ni907
999 C 5 |9 -- missing cx lookup --
|a 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
|2 Crossref
|o 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.bbalip.2014.01.003
|2 Crossref
|o 10.1016/j.bbalip.2014.01.003
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.bbalip.2013.12.018
|2 Crossref
|o 10.1016/j.bbalip.2013.12.018
999 C 5 |9 -- missing cx lookup --
|a 10.1194/jlr.D070565
|2 Crossref
|o 10.1194/jlr.D070565
999 C 5 |9 -- missing cx lookup --
|a 10.1073/pnas.0907864106
|2 Crossref
|o 10.1073/pnas.0907864106
999 C 5 |2 Crossref
|o
999 C 5 |9 -- missing cx lookup --
|a 10.1158/1535-7163.MCT-08-1167
|2 Crossref
|o 10.1158/1535-7163.MCT-08-1167
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00280-011-1612-1
|2 Crossref
|o 10.1007/s00280-011-1612-1
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s10637-010-9529-9
|2 Crossref
|o 10.1007/s10637-010-9529-9
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s10637-011-9772-8
|2 Crossref
|o 10.1007/s10637-011-9772-8
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M110.214866
|2 Crossref
|o 10.1074/jbc.M110.214866
999 C 5 |9 -- missing cx lookup --
|a 10.1089/ars.2007.1800
|2 Crossref
|o 10.1089/ars.2007.1800
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.ceb.2014.03.005
|2 Crossref
|o 10.1016/j.ceb.2014.03.005
999 C 5 |9 -- missing cx lookup --
|a 10.2144/000113610
|2 Crossref
|o 10.2144/000113610
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.cub.2010.05.055
|2 Crossref
|o 10.1016/j.cub.2010.05.055
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.R115.658823
|2 Crossref
|o 10.1074/jbc.R115.658823
999 C 5 |9 -- missing cx lookup --
|a 10.1155/2008/420747
|2 Crossref
|o 10.1155/2008/420747
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s10495-006-0573-z
|2 Crossref
|o 10.1007/s10495-006-0573-z
999 C 5 |9 -- missing cx lookup --
|a 10.1089/dna.2013.2182
|2 Crossref
|o 10.1089/dna.2013.2182
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuropharm.2016.03.033
|2 Crossref
|o 10.1016/j.neuropharm.2016.03.033
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nrneurol.2014.77
|2 Crossref
|o 10.1038/nrneurol.2014.77
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neulet.2015.04.001
|2 Crossref
|o 10.1016/j.neulet.2015.04.001
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00439-004-1199-2
|2 Crossref
|o 10.1007/s00439-004-1199-2
999 C 5 |9 -- missing cx lookup --
|a 10.1523/JNEUROSCI.4798-06.2007
|2 Crossref
|o 10.1523/JNEUROSCI.4798-06.2007
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroscience.2011.12.023
|2 Crossref
|o 10.1016/j.neuroscience.2011.12.023


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21